查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595316

药用明胶市场：按来源、类型、特征和应用分类 - 2025-2030 年全球预测

Pharmaceutical Gelatin Market by Source (Bovine Bone, Bovine Skin, Marine), Type (Type A, Type B), Function, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药用明胶市场价值为12亿美元，预计2024年将达12.8亿美元，复合年增长率为6.44%，预计2030年将达到18.6亿美元。

药用明胶是一种重要的赋形剂，主要用于胶囊壳和锭剂配方以及作为各种药品的稳定剂。其需求是由于其生物相容性和快速溶解能力，使其成为向人体输送药物的理想选择。明胶最常见的用途是软胶囊、硬胶囊和血浆替代。最终用途部门主要是生产口服、眼科和局部给药系统的製药公司。

主要市场统计
基准年[2023] 12亿美元
预测年份 [2024] 12.8亿美元
预测年份 [2030] 18.6亿美元
复合年增长率（%） 6.44%

由于胶囊易于摄取且生物利用度提高，药用明胶市场受到胶囊需求不断增长的显着影响。除了非传染性疾病的快速增加之外，老年人口的增加也推动了对明胶的需求。监管机构对改善给药系统的关注进一步推动了该领域的创新。特别是，随着素食趋势的增长和消费者对动物福利意识的提高，市场面临着开发替代植物来源明胶的机会。公司可以透过投资新型永续明胶配方的研发来利用这一点。从地理位置来看，亚太地区的新兴市场，特别是中国和印度，由于医疗基础设施的扩大和消费者在药品上的支出增加，潜力巨大。

然而，市场面临限制，包括严格的监管标准、原材料价格波动以及牛和猪的采购，特别是由于牛脑病变（BSE）等疾病的爆发。挑战在于平衡成本、品质和遵守良好生产规范 (GMP) 等国际标准。

创新领域包括生物工程明胶以增强机械性能和稳定性的分子控制，以及明胶在定製药物传输系统中的使用。此外，製药公司和研究机构之间的合作研究倡议可以带来创新的产品应用和配方。市场需要敏捷性，企业必须跟上技术进步和不断变化的消费者偏好，以保持竞争力。

市场动态：揭示快速发展的药用明胶市场的关键市场洞察

供需的动态交互作用正在改变药用明胶市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 药用明胶的大规模使用
    • 慢性病及感染疾病流行
    • 临床试验和药物前期研究增加
  • 市场限制因素
    • 与药用明胶相关的高成本
  • 市场机会
    • 明胶奈米粒子在疫苗和药物传输的最新进展
    • 改善供应链和分销网络
  • 市场挑战
    • 对药用明胶安全和品质的担忧

波特五力：驾驭药用明胶市场的策略工具

波特的五力框架是了解药用明胶市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对药用明胶市场的影响

外部宏观环境因素在塑造药用明胶市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药用明胶市场的竞争状况

对药用明胶市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药用明胶市场供应商绩效评估

FPNV 定位矩阵是评估药用明胶市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘药用明胶市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，药用明胶市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 明胶在药物剂量中的大规模使用
      • 慢性病和感染疾病的盛行率
      • 临床试验和初步药物研究的增加
    • 抑制因素
      • 与药用明胶相关的高成本
    • 机会
      • 明胶奈米粒子在疫苗和药物传输的最新进展
      • 改善供应链和分销网络
    • 任务
      • 对药用明胶安全和品质的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药用明胶市场：依来源分类

  • 牛
  • 牛皮
  • 海洋
  • 猪肉
  • 家禽

第七章药用明胶市场：依类型

  • A型
  • B型

第八章药用明胶市场：依功能分类

  • 胶凝剂
  • 稳定剂
  • 增稠剂

第九章药用明胶市场：依应用分类

  • 可吸收止血材料
  • 硬胶囊
  • 软胶囊
  • 药片

第十章美洲药用明胶市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太药用明胶市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲药用明胶市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Gelco International
  • Gelita AG
  • Gelnex
  • Geltec Private Limited
  • Geltech Co. Ltd.
  • Henan Boom Gelatin Co. Ltd.
  • India Gelatine & Chemicals Ltd.
  • Italgel Srl
  • Junca Gelatines SL
  • Kenney & Ross Limited
  • Lapi Gelatine SpA
  • SAS Gelatines Weishardt
  • Tessenderlo Group NV
  • Toudongbao Biotechnology Co., Ltd.
  • Xiamen Gelken Gelatin Co., Ltd.
Product Code: MRR-4F4C36263656

The Pharmaceutical Gelatin Market was valued at USD 1.20 billion in 2023, expected to reach USD 1.28 billion in 2024, and is projected to grow at a CAGR of 6.44%, to USD 1.86 billion by 2030.

Pharmaceutical gelatin is a critical excipient used primarily in the formulation of capsule shells, tablets, and as a stabilizer in various medicinal products. Its necessity stems from its biocompatibility and ability to dissolve rapidly, making it ideal for drug delivery in the human body. Gelatin's most common applications are in soft gel capsules, hard capsules, and blood plasma substitutes. End-use sectors primarily include pharmaceutical companies manufacturing oral, ophthalmic, and topical delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 1.20 billion
Estimated Year [2024] USD 1.28 billion
Forecast Year [2030] USD 1.86 billion
CAGR (%) 6.44%

The market for pharmaceutical gelatin is significantly influenced by the rising demand for capsules due to their ease of consumption and improved bioavailability. An increasing geriatric population, alongside the surging occurrence of non-communicable diseases, boosts gelatin demand. Regulatory bodies' emphasis on improving drug delivery systems further fuels innovation in this sector. Notably, the market faces opportunities in developing plant-based gelatin alternatives, driven by a growing veganism trend and rising consumer awareness regarding animal welfare. Companies can capitalize on this by investing in R&D toward novel, sustainable gelatin formulations. Geographically, emerging markets in Asia-Pacific, particularly China and India, offer vast potential due to expanding healthcare infrastructure and rising consumer spending on pharmaceuticals.

However, the market confronts limitations, including stringent regulatory norms and volatility in raw material prices, especially concerning bovine and porcine sourcing due to disease outbreaks like Bovine Spongiform Encephalopathy (BSE). The challenge lies in balancing cost, quality, and compliance with international standards such as Good Manufacturing Practices (GMP).

Innovative areas include bio-engineered gelatin, which enhances molecular control over mechanical properties and stability, and gelatin's utilization in customized drug delivery systems. Moreover, collaborative research initiatives between pharmaceutical companies and research institutions may yield innovative product applications and formulations. The market demands agility, requiring firms to synchronize with technological advancements and evolving consumer preferences to maintain a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Gelatin Market

The Pharmaceutical Gelatin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Large scale use of gelatin in pharma drug dosage
    • Prevalence of chronic and infectious disorders
    • Increasing clinical trials and preliminary drug studies
  • Market Restraints
    • High cost associated with Pharmaceutical Gelatin
  • Market Opportunities
    • Recent advancements in gelatin nanoparticle in vaccine and drug delivery
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Safety and quality concerns with pharmaceutical gelatin

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Gelatin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Gelatin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Gelatin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Gelatin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Gelatin Market

A detailed market share analysis in the Pharmaceutical Gelatin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Gelatin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Gelatin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Gelatin Market

A strategic analysis of the Pharmaceutical Gelatin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Gelatin Market, highlighting leading vendors and their innovative profiles. These include Gelco International, Gelita AG, Gelnex, Geltec Private Limited, Geltech Co. Ltd., Henan Boom Gelatin Co. Ltd., India Gelatine & Chemicals Ltd., Italgel S.r.l., Junca Gelatines SL, Kenney & Ross Limited, Lapi Gelatine S.p.A, SAS Gelatines Weishardt, Tessenderlo Group NV, Toudongbao Biotechnology Co., Ltd., and Xiamen Gelken Gelatin Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Gelatin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source, market is studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry.
  • Based on Type, market is studied across Type A and Type B.
  • Based on Function, market is studied across Gelling Agents, Stabilizing Agents, and Thickening Agents.
  • Based on Application, market is studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Large scale use of gelatin in pharma drug dosage
      • 5.1.1.2. Prevalence of chronic and infectious disorders
      • 5.1.1.3. Increasing clinical trials and preliminary drug studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with Pharmaceutical Gelatin
    • 5.1.3. Opportunities
      • 5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Gelatin Market, by Source

  • 6.1. Introduction
  • 6.2. Bovine Bone
  • 6.3. Bovine Skin
  • 6.4. Marine
  • 6.5. Porcine
  • 6.6. Poultry

7. Pharmaceutical Gelatin Market, by Type

  • 7.1. Introduction
  • 7.2. Type A
  • 7.3. Type B

8. Pharmaceutical Gelatin Market, by Function

  • 8.1. Introduction
  • 8.2. Gelling Agents
  • 8.3. Stabilizing Agents
  • 8.4. Thickening Agents

9. Pharmaceutical Gelatin Market, by Application

  • 9.1. Introduction
  • 9.2. Absorbable Hemostats
  • 9.3. Hard Capsules
  • 9.4. Soft Capsules
  • 9.5. Tablets

10. Americas Pharmaceutical Gelatin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Gelatin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Gelatin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Gelco International
  • 2. Gelita AG
  • 3. Gelnex
  • 4. Geltec Private Limited
  • 5. Geltech Co. Ltd.
  • 6. Henan Boom Gelatin Co. Ltd.
  • 7. India Gelatine & Chemicals Ltd.
  • 8. Italgel S.r.l.
  • 9. Junca Gelatines SL
  • 10. Kenney & Ross Limited
  • 11. Lapi Gelatine S.p.A
  • 12. SAS Gelatines Weishardt
  • 13. Tessenderlo Group NV
  • 14. Toudongbao Biotechnology Co., Ltd.
  • 15. Xiamen Gelken Gelatin Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GELATIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GELATIN MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY MARINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY GELLING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY STABILIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY ABSORBABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2023